Introduction Cerebral amyloid angiopathy (CAA) is a common type of cerebral small vessel disease (SVD) characterized by amyloid-beta deposition in the leptomeningeal and cortical cerebral vessels.1–3 In addition to (recurrent) lobar intracerebral hemorrhages (ICH) and transient focal neurological episodes, many patients with CAA experience cognitive symptoms or even dementia independently from commonly co-occurring Alzheimer’s disease (AD).4–7 While ICH is a contributor to the development of...